Healthy adult
Conditions
Interventions
Continuous intake of one packet of the test article A daily before bedtime for 8 weeks.
Continuous intake of one packet of the test article B daily before bedtime for 8 weeks.
Continuous intake of one
Sponsors
Japan Clinical Trial Association
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects dissatisfied with or concerned about their sleep quality 2. Subjects experiencing fatigue in daily life 3. Subjects with a BMI between 19 and 26 4. Subjects who use a smartphone and can download and use an app.
Exclusion criteria
Exclusion criteria: 1. Subjects satisfied with their sleep quality, somewhat satisfied, or neither satisfied nor dissatisfied 2. Pregnant women, breastfeeding individuals, or those who may be pregnant 3. Subjects working night shifts or rotating day-night shifts 4. Subjects currently receiving medical treatment or taking prescription medication 5. Subjects diagnosed by a physician with sleep disorders such as insomnia 6. Subjects taking sleeping pills or sleep supplements (e.g., melatonin) 7. Subjects undergoing hormone replacement therapy 8. Subjects who participated in another human trial within the past month or are currently participating in one 9. Subjects whose trial date falls within 2 weeks of their most recent vaccination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OSA sleep inventory MA version, VAS, Instrumental measurement | — |
Countries
Japan
Contacts
Public ContactTakeshi Kaneko
Japan Clinical Trial Association N.A.
Outcome results
None listed